放射治疗期间治疗终止:10年经验
该研究在一个大型多中心放射肿瘤科前瞻性分析2013年1月至2023年1月期间的治疗终止(TT)病例,TT定义为启动放疗计划后任何提前终止治疗。31,199个计划疗程中识别出1448例TT(4.6%),TT率从2013年8.49%逐年降至2022年3.02%。
要点
- 31,199个计划疗程中TT共1448例(4.6%),其中根治性686例(47.4%)、姑息性753例(52.0%)、良性疾病9例(0.6%)。
- TT率从2013年8.49%降至2022年3.02%,逐年下降。
- TT最常见疾病部位为中枢神经系统(21.7%)、头颈(19.3%)、胸部(17.5%)和骨(14.2%)。
核心结论
- 这项10年前瞻性TT审查发现,TT占计划患者的比例逐年下降。
- TT下降可能与增加TT根本原因审查及每月发病率与死亡率讨论会、并结合科室随时间实施的上游质量改进措施有关。
- 了解TT背后的原因可能有助于减少可预防的TT;尽管部分TT可能不可避免,公开讨论和质量改进变化可随时间有效减少TT事件。
研究设计与样本
- 前瞻性分析2013年1月至2023年1月期间在一个大型多中心放射肿瘤科发生的TT,作为持续科室质量与安全项目的一部分。
- TT定义为启动放疗计划后任何提前终止治疗;TT率按占所有启动放疗计划患者的百分比计算。
- 所有病例在每月发病率与死亡率会议上呈现并审查根本原因。
主要发现
- 31,199个计划疗程中识别出1448例TT(4.6%)。
- 686例(47.4%)为根治性意图患者,753例(52.0%)为姑息性意图,9例(0.6%)为良性疾病治疗。
- TT率从2013年8.49%降至2022年3.02%,逐年下降。
- TT最常见疾病部位为中枢神经系统(21.7%)、头颈(19.3%)、胸部(17.5%)和骨(14.2%)。
- TT最常见原因为临终关怀和/或患者死亡(35.9%)、与毒性无关的患者选择(35.2%)和与毒性无关的临床医生选择(11.5%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients undergoing radiation therapy may terminate treatment for any number of reasons. The incidence of treatment termination (TT) during radiation therapy has not been studied. Herein, we present a cohort of TT at a large multicenter radiation oncology department over 10 years. METHODS AND MATERIALS: TTs between January 2013 and January 2023 were prospectively analyzed as part of an ongoing departmental quality and safety program. TT was defined as any premature discontinuation of therapy after initiating radiation planning. The rate of TT was calculated as a percentage of all patients starting radiation planning. All cases were presented at monthly morbidity and mortality conferences with a root cause reviewed. RESULTS: A total of 1448 TTs were identified out of 31,199 planned courses of care (4.6%). Six hundred eighty-six (47.4%) involved patients treated with curative intent, whereas 753 (52.0%) were treated with palliative intent, and 9 (0.6%) were treated for benign disease. The rate of TT decreased from 8.49% in 2013 to 3.02% in 2022, with rates decreasing yearly. The most common disease sites for TT were central nervous system (21.7%), head and neck (19.3%), thorax (17.5%), and bone (14.2%). The most common causes of TT were hospice and/or patient expiration (35.9%), patient choice unrelated to toxicity (35.2%), and clinician choice unrelated to toxicity (11.5%). CONCLUSIONS: This 10-year prospective review of TTs identified a year-over-year decrease in TTs as a percentage of planned patients. This decrease may be associated with the addition of root cause reviews for TTs and discussions monthly at morbidity and mortality rounds, coupled with departmental upstream quality initiatives implemented over time. Understanding the reasons behind TTs may help decrease preventable TTs. Although some TTs may be unavoidable, open discourse and quality improvement changes effectively reduce TT incidents over time.
引用
- Nosrati JD, Ma D, Bloom B, et al. Treatment Terminations During Radiation Therapy: A 10-Year Experience. Pract Radiat Oncol. 2024. PMID: 38972541. doi:10.1016/j.prro.2024.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。